THE INDIAN TECH GUY

The coronavirus "may never go away", the World Health Organization (WHO) has warned. Speaking at a briefing on Wednesday, WHO emergencies director Dr Mike Ryan warned against trying to predict when the virus would disappear. He added that even if a vaccine is found, controlling the virus will require a "massive effort". Almost 300,000 people worldwide are reported to have died with coronavirus, and more than 4.3m cases recorded. The UN meanwhile warned the pandemic was causing widespread distress and mental ill health - particularly in countries where there's a lack of investment in mental healthcare. The UN urged governments to make mental health considerations part of their overall response. What did WHO say? "It is important to put this on the table: this virus may become just another endemic virus in our communities, and this virus may never go away," Dr Ryan told the virtual press conference from Geneva. "HIV has not

Coronavirus has Americans picking up two new summer accessories: a mask and an alcoholic to-go drink. After weeks of sheltering in place, many Americans are looking for ways to cut loose. With bars and restaurants closed to the public in most states, and summer weather approaching, that means that many are heading outdoors to relax and socialise. And for some, that means having a drink - sometimes in spite of the law. Veteran drinks writer Amanda Schuster says that in her neighbourhood of Brooklyn, New York, "it seems like everyone's over" prohibitions on public drinking. "It's as if people have the attitude that 'no one's going to arrest us for this when they have other things to do,'" Ms Schuster, who is the editor-in-chief for online magazine Alcohol Professor, told the BBC. This laissez-faire approach is something Americans used to have to go abroad to experience. While an 18-year-old can walk into a London pub and or

A former top US health official has told Congress the country could face its "darkest winter in modern history" because of the coronavirus. Rick Bright led the government agency trying to develop a vaccine, but was removed from his post last month. He has previously said he was ousted from the job for raising concern over a treatment being touted by President Donald Trump. The US leader dismissed him as a "disgruntled" employee. 'Ousted' US vaccine expert to file complaint Senate intelligence chief steps down for FBI probe How the pandemic is relaxing US drinking laws Mr Bright also told the House of Representatives subcommittee on health "lives were lost" because of government "inaction" in the early stages of the outbreak. He said he first spoke out about a medical equipment shortage in January, raising the issue to the "highest levels" of the Department of Health and Human Services (HHS), but "go

After more than 40 state-wide lockdowns were put in place across the US throughout March and April, many states are now easing restrictions - but some are going against White House guidelines, worrying public health experts. Dr Anthony Fauci, the White House's top infectious disease adviser, has said he's concerned some states are opening up too soon and risk triggering "an outbreak that you may not be able to control". Dr Fauci said: "I've been very clear in my message to try, to the best extent possible, to go by the guidelines that have been very well thought out and very well delineated." What are the guidelines? The reopening guidelines laid out by the Trump administration in April propose that states should have a "downward trajectory" of reported cases, or a falling share of positive tests, over a 14-day period before beginning a gradual reopening. They also say states should have a robust testing programme in p

US President Donald Trump has said a sobering warning by his top infectious diseases expert about lifting pandemic restrictions too soon was unacceptable. He accused Dr Anthony Fauci of wanting "to play all sides of the equation" in his testimony to lawmakers on Tuesday. The president said he was especially dissatisfied with Dr Fauci's caution around reopening schools too quickly. Covid-19 has infected nearly 1.4 million people in the US and killed 84,000, while ravaging the economy. Things the US has got right - and got wrong Fed warns of slow recovery without more virus aid US accuses China of hacking coronavirus research What did the US president say? Speaking on Wednesday at the White House, Mr Trump took issue with Dr Fauci's comments to a Senate hearing a day earlier about the risks to children of reopening and his assessment that a vaccine was unlikely before classes could begin this autumn. "Look, he wants to play all sides of th

Site Audit Interactive Traffic Analytics Backlink Analytics Domain, Keyword or Organic The SEMrush Sensor

#1 69% HP Pavilion Gaming 15-ec0062AX (9LA60PA) Laptop (AMD Quad Core Ryzen 5/8 GB/1 TB 128 GB SSD/Windows 10/3 GB) Windows 10 Rs. 49,990 Performance AMD Quad Core Ryzen 5 2.1 Ghz 8 GB DDR4 RAM 3 GB Graphics Design 15.6 inches (39.62 cm) 1920 x 1080 pixels 1.98 Kg, 23.5 mm thick Storage 1 TB HDD 128 GB SSD SATA 5400 RPM Battery Li-Ion 3 Cell + Compare #2 65% Acer Chromebook CB3-431-C5FM (NX.GC2AA.007) Laptop (Celeron Quad Core/4 GB/32 GB SSD/Google Chrome)

A mobile banking malware called "EventBot", which steals personal financial information, may affect Android phone users in India, the federal cyber-security agency has said in a latest advisory. The CERT-In has issued a caution, saying the Trojan virus may "masquerade as a legitimate application such as Microsoft Word, Adobe Flash, and others using third-party application downloading sites to infiltrate into victim device". A Trojan is a virus or malware that cheats a victim to stealthily attack its computer or phone-operating system. "It has been observed that a new Android mobile malware named EventBot is spreading. "It is a mobile-banking Trojan and info-stealer that abuses Android''s in-built accessibility features to steal user data from financial applications, read user SMS messages and intercept SMS messages, allowing malware to bypass two-factor authentication," the CERT-In advisory said. The Computer Emergency Respons

Sony on Thursday said it would make its cash-cow image sensors smarter to broaden their application, as the Japanese electronics maker seeks to reduce reliance on a saturated smartphone market. The company said it has developed the world's first image sensor with an integrated artificial intelligence (AI) processor, which can perform tasks such as determining the size of a crowd, scanning bar codes and monitoring a driver's drowsiness - all in a single chip. As an AI processor is stacked on an image-sensing chip, the complete package can extract and process data without sending it to the cloud or elsewhere, eliminating transmission latency and reducing power consumption, Sony said. The move underscores how the Japanese giant, whose once-dominant position in consumer electronics has been eroded by Asian rivals, still has a strong arsenal of sophisticated technology in areas like sensors and robotics. Sony's chip business earns roughly 90 percent of revenue

Vivo V19 is all set to go on sale in India for the first time today. The phone was launched earlier this week, and it will now be available via Amazon, Flipkart, the company's e-store, other e-commerce websites, and partner offline stores across the country. The company has revealed a slew of launch offers and it has partnered with HDFC Bank and ICICI Bank to offer 10 percent cashback on all credit card or credit card EMI purchases. Vivo V19 comes with dual selfie cameras and a quad camera setup at the back. It is important to note that e-retailers will only be taking orders for the phone from customers living in Orange and Green zones in the country. Vivo V19 price in India, availability, launch offers The Vivo V19 price in India is set at Rs. 27,990 for the 8GB + 128GB storage option and at Rs. 31,990 for the 8GB + 256GB storage option. It will go on sale on sale from today via the company's own e-store, Amazon, Flipkart, other e-commerce websites, and partn

As long, jostling queues formed outside liquor stores in India during the easing of a coronavirus lockdown, Karthik Velayutham found a way to maintain social distancing -- by building a robot to shop for him. The humble machine -- a cardboard box resting on a four-wheel wooden platform -- took the computer engineer two days to make and cost Rs. 3,000 rupees. But it is performing a crucial job for its creator at a time when social interactions carry the risk of catching the coronavirus that has infected more than four million people and killed over 297,000 worldwide. "I ran my robot to the wine shop as a trial to demonstrate how someone can use it in a crowded place and to create awareness about the importance of social distancing to prevent the spread of coronavirus," Velayutham, 31, told AFP. "I have tested this device on the streets and it has no problems and goes smoothly, even over speed bumps because I have used a gear motor." Velayutham co

RBI/2019-20/231 DOR.Dir.BC.No.69/04.02.001/2019-20 May 13, 2020 All Scheduled Commercial Banks (excluding RRBs) Small Finance Banks, Primary (Urban) Cooperative Banks and EXIM Bank Dear Sir / Madam, Interest Equalisation Scheme on Pre and Post Shipment Rupee Export Credit-Extension Please refer to the operational instructions for the captioned Scheme contained in RBI circular on Interest Equalisation Scheme on Pre and Post Shipment Rupee Export Credit issued vide DBR.Dir.BC.No.62/04.02.001/2015-16 dated December 4, 2015 ; DCBR.CO.SCB.Cir.No.1/13.05.000/2015-16 dated February 11, 2016 , DBR.Dir.BC.No.09/04.02.001/2018-19 dated November 29, 2018 and DBR.Dir.BC.No.22/04.02.001/2018-19 dated January 11, 2019 . 2. In this connection, Government of India has approved the extension of Interest Equalization Scheme for pre and post shipment Rupee export credit, with same scope and coverage, for one more year i.e. upto March 31, 2021. Th

फ़्रांसिसी दवा कंपनी सेनोफ़ी के कोविड-19 टीके के शोध में अमरीका की संस्था यूएस बायोमेडिकल ऐडवांस्ड रिसर्च ऐंड डेवलपमेंट ऑथोरिटी (बार्डा) ने निवेश किया है. मगर सेनोफ़ी को हाल के वर्षों में फ़्रांस सरकार से उसके शोध कार्यों में सहायता के लिए लाखों यूरो के करों में छूट मिली है. कंपनी ने इसके अलावा पिछले महीने ब्रिटेन की कंपनी ग्लैक्सोस्मिथक्लाइन के साथ मिलकर एक टीका बनाने के लिए समझौता किया है. कोरोना वायरस पर शोध के लिए इस महीने एक अंतरराष्ट्रीय ऑनलाइन सम्मेलन भी हुआ जिसकी अध्यक्षता यूरोपीय संघ ने की. सम्मेलन में लगभग 40 देशों ने 8 अरब डॉलर का चंदा देने का संकल्प किया. अमरीका और रूस ने इसमें हिस्सा नहीं लिया. यूरोपीय संघ ने ज़ोर देकर कहा है कि सभी देशों का टीके पर समान अधिकार होना चाहिए. फ्रांस के एक मंत्री ने चेतावनी दी है कि फ़्रेंच दवा कंपनी सेनोफ़ी अगर कोविड-19 का टीका बनाती है और अमरीका के बाज़ार को प्राथमिकता देती है तो इसे कतई स्वीकार नहीं किया जाएगा. फ़्रांस के उप वित्त मंत्री एग्नस पैनिए-रूनाशर ने इस कंपनी के सीईओ की बातों पर प्रतिक्रिया देते हुए ये